133 related articles for article (PubMed ID: 2323625)
1. Synergistic cytotoxicity of cytosine arabinoside and mitoxantrone for K562 and CFU-GM.
Krehmeier C; Zühlsdorf M; Büchner T; Hiddemann W
Haematol Blood Transfus; 1990; 33():129-32. PubMed ID: 2323625
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia.
Stiff PJ; Schulz WC; Bishop M; Marks L
Blood; 1991 Jan; 77(2):355-62. PubMed ID: 1985700
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
Fountzilas G; Inoue S; Ohnuma T
Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478
[TBL] [Abstract][Full Text] [Related]
4. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment.
Lista P; Brizzi MF; Rossi M; Resegotti L; Clark SC; Pegoraro L
Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644
[TBL] [Abstract][Full Text] [Related]
5. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
[TBL] [Abstract][Full Text] [Related]
6. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
Muus P; Haanen C; Raijmakers R; de Witte T; Salden M; Wessels J
Semin Oncol; 1987 Jun; 14(2 Suppl 1):238-44. PubMed ID: 3473679
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
Cannistra SA; Groshek P; Griffin JD
Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
[TBL] [Abstract][Full Text] [Related]
8. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
De Witte T; Muus P; Haanen C; Van der Lely N; Koekman E; Van der Locht A; Blankenborg G; Wessels J
Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
[TBL] [Abstract][Full Text] [Related]
10. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
11. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
Waga K; Furusawa S; Nagashima S; Saito K; Shishido H
Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
[TBL] [Abstract][Full Text] [Related]
13. The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells.
Loughlin S; Gandhi V; Plunkett W; Zwelling LA
Cancer Chemother Pharmacol; 1996; 38(3):261-8. PubMed ID: 8646801
[TBL] [Abstract][Full Text] [Related]
14. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
Bhalla K; MacLaughlin W; Cole J; Arlin Z; Baker M; Graham G; Grant S
Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C).
Marie JP; Zittoun R
Med Pediatr Oncol; 1982; 10 Suppl 1():263-7. PubMed ID: 6962323
[TBL] [Abstract][Full Text] [Related]
16. [The effect of interferon alone, cytosine arabinoside alone and their combined effect on hematopoietic progenitors of chronic myeloid leukemia in vitro].
Qin H; Yang Y; Liang Y; Li Y; Zeng L
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):281-4. PubMed ID: 12575210
[TBL] [Abstract][Full Text] [Related]
17. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
Marley SB; Davidson RJ; Goldman JM; Gordon MY
Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
[TBL] [Abstract][Full Text] [Related]
19. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
Lech-Maranda E; Korycka A; Robak T
Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
[TBL] [Abstract][Full Text] [Related]
20. Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
Giallongo C; La Cava P; Tibullo D; Parrinello N; Barbagallo I; Del Fabro V; Stagno F; Conticello C; Romano A; Chiarenza A; Palumbo GA; Di Raimondo F
Eur J Haematol; 2011 Mar; 86(3):216-25. PubMed ID: 21198861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
